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WHEN Professor Pantridge in 1966 emulated the idea of Napoleon's surgeon, Larrey, and
took intensive care to the patient, he not only initiated a service which altered the high rate
of mortality of patients suffering from the acute coronary attack, but also uncovered a whole
new region of cardiac patho-physiology.
It was known that two-thirds of premature deaths occurred within one hour of the onset of
symptoms, so that the majority of patiens died ouside hospital. For those lucky enough to
reach hospital alive intensive care units were already developed or being developed. In Belfast
in 1965 hospital admission was in a large proportion of patients delayed for more than twelve
hours and the median delay was more than eight hours. In other cities it was at least equally
bad and often worse.
By 1969, three years after the introduction of the mobile cardiac resuscitation service,
27.5 per cent of affected patients came under intensive care within one hour, and the median
delay for admission had been reduced to one hour forty minutes.
The introduction of the patient to early medical care engendered new problems-a higher
incidence of vagal bradycardia and of ventricular fibrillation than in those patients who had
formerly been admitted to the coronary care units. Fortunately, inethods of cardiac resuscita-
tion were being developed. In 1960 Koventhoven had shown the possibility of external cardiac
massage, whilst the value of direct current or capacitor discharge had been demonstrated in
the correction of ventricular fibrillation. Vagal bradycardia could be abolished by atropine
and other dysrhythmias and autonomic disturbances rectified. Nor in this wealth of physical
and pharmacological therapeusis was the patiernt forgotten. Anxiety and pain could be greatly
modified by heroin and other drugs.
In a series of seven chapters this monograph clearly sets out the problems of the patient
with an acute coronary attack. Early diagnosis and therapy are shown not only to reduce
mortality, but in many cases to limit the size of the area of infarction and to decrease the
incidence of cardiac shock and of pump failure. Numerous methods are shown to be available
for improving the chances for survival of ischaemic myocardium and hence increase the
possibility of the re-establishment of sufficient cardiac function to allow the patient's return
to a normal way of life. Indeed, these observations constitute the most pungent reasons for the
development of early rational treatment.
Obviously early cardiac treatment is not always available. Potential patients must be alerted
as to the danger: early treatment must be made available: general pracitioners must be
trained and must have in their possession for immediate use defibrillators and the small
quantum of the necessary drugs. Differing areas demand different solutions, but the necessary
equipment is not excessive. To this end Professor Pantridge and his team have given their
minds to the development of a smaller, less expensive, more transportable, but equally effective
defibrillator, reducing weight from 55 lbs to 7 lbs, and there is hope that it can be still further
miniaturised. Indeed, it may become possible for every general practitioner-and indeed para-
medical personnel-each to have his own.
Considering that cardiovascular disease is the most frequent cause of death, that our know-
ledge of methods of prevention of coronary attacks is still so tenuous, these summated efforts
of the Belfast group have an immense role to play. There is a role for everyone-the public
themselves who will eventually be the patients-the general practitioner who must be furbished
with the necessary impedimenta-paramedical personnel who must be trained-administrators
99who must be taught to facilitate, and cardiologists who must continue to ask the right ques-
tions of the problems involved and strive to seek the answers to them.
Professor Pantridge and his team are to be congratulated on their initiative, on their vision
in seeing what the essential problems are and on their pertinacity in pressuring their aims.
Their thesis is well argued.
J.H.B.
A MANUAiL OF ADVERSE DRUG INTERACTIONS. By J. P. Griffin and P. F.
D'Arcy. (Pp. XII + 347, figures 13. £7.00). Bristol: Wright. 1973.
THIS excellent little book meets the need for all prescribing doctors for up-to-date guidance
on how to prevent adverse reactions when they prescribe more than one drug to a patient. It
contains a 48-page text which explains the mechanisms of drug interactions with extreme
clarity using examples which are within the experience of most prescribing doctors. This text
is divided into chapters on reactions which occur before the patient receives the drug (in the
drip bottle, etc.) in the gut and intestinal wall, in the blood at the receptor site and so on. It is
well illustrated and has a good selection of references for those who wish to follow up any
particular aspect of the problem.
The bulk of the book consists of an alphabetical list of drug groupings "Anticoagulants",
"Antihypertensives", "General Anaesthetic Agents", etc., with an index which includes both
the official and the proprietary names of all the drugs. Unlike most of the tables that are
available for this purpose, this one is arranged so that you can discover both what inter-
actions may develop if you add a new drug to a long-term medication, but also those likely
on the simultaneous initiation of treatment with two or more drugs. The other advance is that
there is excellent advice on how to avoid serious adverse reactions by care with dosage and
monitoring of blood levels, etc. In previous tables of this sort it was implied that combin-
ations of drugs reported to have caused adverse reactions should be avoided altogether. This
table tells you how to use the combination, get the benefit of both drugs and at the same
time avoid an adverse reaction.
This is a field of rapid advances in knowledge. One must congratulate the authors in getting
their book into print so quickly that it is reasonably up-to-date. One does not envy them the
task of keeping up-to-date because this requires a new edition every 2-3 years.
I wish every prescribing doctor would read the first 48 pages of this book and would refer
to the table whenever he embarks on multiple prescribing.
P.C.E.
HEMATOLOGY PHYSIOLOGIC, PATHOPHYSIOLOGIC, ANiD CLINICAL
PRINCIPLES. By J. W. Linman. (Pp. XIII + 1055; illustrated. £21). New
York: MacMillan Publishing Co. Inc. 1975.
THIS is a further addition to the large and expanding range of general textbooks in haema-
tology. Although a new addition, it is based on "The Principles of Haematology" by the same
author, which was first published in 1966 and from which part of the material is obtained.
The claim on the dust cover is that "This clinically oriented reference volume presents
up-to-date information on the diagnosis and treatment of all types of haematologic disorders,
both primary and secondary. Its goal is to provide descriptions of disease based on modern
physiologic and pathophysiologic concepts".
The presentation follows the traditional pattern and the chapters indicate the extent of the
subject coverage. The only quarrel which British readers might have is with some of the
trans-Atlantic nomenclature. We had hoped that the 'rubriblast' and its progeny had been
decently buried, and that the synonym of 'agnogenic myeloid metaplasia' had at long last been
supplanted.
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